Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPL vs TPT for MGD-associated Dry Eye Disease
NCT06745089Completed
- Sponsor
- National Yang Ming Chiao Tung University
- Start
- Jul 2022
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Randomised, open-label trial in meibomian gland dysfunction (MGD) and dry eye disease (DED) (3 arms), sponsored by National Yang Ming Chiao Tung University. Primary endpoint: Ocular Surface Disease Index at 5 months. Started Jul 2022; status: completed.
02
Conditions
meibomian gland dysfunction (MGD)dry eye disease (DED)
Beyond the preview
Go deeper on NCT06745089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06745089.